Literature DB >> 15505179

In vivo evidence of neuronal loss in the hypothalamus of narcoleptic patients.

R Lodi1, C Tonon, L Vignatelli, S Iotti, P Montagna, B Barbiroli, G Plazzi.   

Abstract

A dysfunction of the orexin (hypocretin) system in the hypothalamus has recently been linked to the pathogenesis of narcolepsy. The authors used in vivo proton MR spectroscopy to assess the N-acetylaspartate (NAA) content in the hypothalamus of narcoleptic patients. Hypothalamic NAA/creatine-phosphocreatine was reduced in narcoleptic patients compared with control subjects (p < 0.01). Hypothalamic neuronal loss/damage is a central pathogenetic feature in narcolepsy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15505179     DOI: 10.1212/01.wnl.0000142259.94107.4c

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

Review 1.  Narcolepsy: immunological aspects.

Authors:  Sebastiaan Overeem; John Logan Black; Gert Jan Lammers
Journal:  Sleep Med Rev       Date:  2008-03-04       Impact factor: 11.609

2.  Reduction in hypothalamic 1H-MRS metabolite ratios in patients with cluster headache.

Authors:  S-J Wang; J-F Lirng; J-L Fuh; J-J Chen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-05       Impact factor: 10.154

Review 3.  Neuroimaging findings in narcolepsy with cataplexy.

Authors:  Thien Thanh Dang-Vu
Journal:  Curr Neurol Neurosci Rep       Date:  2013-05       Impact factor: 5.081

4.  Increased GABA levels in medial prefrontal cortex of young adults with narcolepsy.

Authors:  Seog Ju Kim; In Kyoon Lyoo; Yujin S Lee; Young Hoon Sung; Hengjun J Kim; Jihyun H Kim; Kye Hyun Kim; Do-Un Jeong
Journal:  Sleep       Date:  2008-03       Impact factor: 5.849

Review 5.  Neuroimaging insights into the pathophysiology of sleep disorders.

Authors:  Martin Desseilles; Thanh Dang-Vu; Manuel Schabus; Virginie Sterpenich; Pierre Maquet; Sophie Schwartz
Journal:  Sleep       Date:  2008-06       Impact factor: 5.849

6.  Evidence for metabolic hypothalamo-amygdala dysfunction in narcolepsy.

Authors:  Rositsa Poryazova; Betina Schnepf; Esther Werth; Ramin Khatami; Ulrike Dydak; Dieter Meier; Peter Boesiger; Claudio L Bassetti
Journal:  Sleep       Date:  2009-05       Impact factor: 5.849

7.  Narcolepsy: a review.

Authors:  Gbolagade Sunmaila Akintomide; Hugh Rickards
Journal:  Neuropsychiatr Dis Treat       Date:  2011-09-08       Impact factor: 2.570

8.  Differences in brain morphological findings between narcolepsy with and without cataplexy.

Authors:  Masaki Nakamura; Shingo Nishida; Kenichi Hayashida; Yoichiro Ueki; Yves Dauvilliers; Yuichi Inoue
Journal:  PLoS One       Date:  2013-11-28       Impact factor: 3.240

9.  Gray matter concentration abnormality in brains of narcolepsy patients.

Authors:  Eun Yeon Joo; Woo Suk Tae; Sung Tae Kim; Seung Bong Hong
Journal:  Korean J Radiol       Date:  2009 Nov-Dec       Impact factor: 3.500

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.